The first biosimilar for cancer treatment has FDA approval and others are in the pipeline. Doctors say it's too soon to say how it will affect cancer patients.
Industry news
The first biosimilar for cancer treatment has FDA approval and others are in the pipeline. Doctors say it's too soon to say how it will affect cancer patients.
recently published
Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.